Global Lung Laryngeal Stents Market Size By Type (Self-expandable Stents, Balloon-expandable Stents), By Application (Hospitals, Ambulatory Surgery Centres), By Region, And Segment Forecasts, 2023 to...

The Global Lung Laryngeal Stents Market was valued at USD 234 million in 2023 and is projected to reach USD 410 million by 2031, growing at a CAGR of 7.2% during the forecast period from 2023 to 2031. The market's growth is fueled by increasing incidence of chronic respiratory disorders, such as tracheal stenosis, laryngeal cancer, and chronic obstructive pulmonary disease (COPD), which drive the need for stenting procedures. Technological advancements in stent materials and design—such as bioresorbable, drug-eluting, and customized 3D-printed stents—are further supporting market expansion. Rising preference for minimally invasive treatments and growing awareness among healthcare providers regarding airway management are also pivotal contributors.

Drivers

1. Rising Prevalence of Airway Obstruction Disorders

A growing patient population suffering from airway strictures due to tumors, infections, trauma, or post-surgical complications is significantly increasing the demand for lung and laryngeal stents.

2. Advancements in Stent Technology

The introduction of biodegradable and drug-eluting stents has improved patient outcomes by reducing complications like granulation tissue formation and restenosis.

3. Increasing Geriatric Population

With the global population aging rapidly, the incidence of tracheobronchial conditions is on the rise, thereby boosting the demand for long-term airway stenting solutions.

Restraints

1. Risk of Complications and Restenosis

Despite technological improvements, issues like migration, infection, and restenosis continue to present challenges, restraining wider adoption in some clinical settings.

2. High Treatment and Device Costs

The high cost associated with lung laryngeal stenting procedures, particularly with advanced or customized stents, limits accessibility in lower-income regions and for uninsured patients.

Opportunity

1. Expanding Access in Emerging Markets

Countries in Asia-Pacific and Latin America are witnessing improved healthcare infrastructure and increased government focus on respiratory health, presenting untapped potential for market growth.

2. 3D Printing and Customization

The rise of patient-specific, 3D-printed stents enables more precise treatment, reducing complications and improving outcomes—opening avenues for personalized medical care.

Market by System Type Insights

In 2023, the Silicone Stents segment held the largest market share due to their ease of placement and removal, affordability, and lower tissue reactivity. However, the Metallic Stents segment is anticipated to witness the fastest growth owing to better radial force, flexibility, and newer drug-eluting capabilities that reduce inflammation and enhance airway patency.

Market by End-Use Insights

Hospitals dominated the end-use segment in 2023, accounting for over 60% of the market share. Hospitals offer comprehensive respiratory care, advanced diagnostic and procedural capabilities, and a multidisciplinary approach. Meanwhile, ambulatory surgical centers are growing in prominence due to faster service delivery and reduced patient hospitalization costs.

Market by Regional Insights

North America led the global lung laryngeal stents market in 2023, driven by robust healthcare infrastructure, high diagnostic rates, and the early adoption of advanced technologies. However, Asia-Pacific is projected to be the fastest-growing region, thanks to the increasing burden of respiratory diseases, rising healthcare spending, and expanding access to interventional pulmonology procedures in countries like China and India.

Competitive Scenario

Key players in the Global Lung Laryngeal Stents Market include:

Boston Scientific Corporation

Teleflex Incorporated

Novatech SA

Merit Medical Systems, Inc.

Micro-Tech (Nanjing) Co., Ltd.

Cook Medical Inc.

Taewoong Medical Co., Ltd.

Olympus Corporation

These companies focus on product innovation, geographical expansion, and partnerships with hospitals and research institutes. For example:

In 2024, Boston Scientific launched a new range of hybrid stents combining the advantages of both silicone and metal materials to reduce post-operative complications.

In 2023, Teleflex received FDA clearance for its fully biodegradable airway stent designed for temporary intervention in benign airway strictures.

Scope of Work – Global Lung Laryngeal Stents Market

Report Metric Details

Market Size (2023) USD 234 million

Projected Market Size (2031) USD 410 million

CAGR (2023-2031) 7.2%

Market Segments By System Type (Silicone Stents, Metallic Stents), End-Use (Hospitals, ASCs), Region

Growth Drivers Increasing respiratory diseases, stent innovations, aging population

Opportunities 3D printing, expansion in emerging markets

Key Market Developments

2024: Novatech SA expanded its silicone stent product line to include pediatric variants with enhanced flexibility and biocompatibility.

2023: Merit Medical Systems partnered with European healthcare systems to pilot patient-specific stent trials using AI-based airway modeling.

2022: Cook Medical introduced a low-profile stent deployment system to facilitate less-invasive procedures.

FAQs

1) What is the current market size of the Global Lung Laryngeal Stents Market?

The market was valued at USD 234 million in 2023.

2) What is the major growth driver of the Global Lung Laryngeal Stents Market?

Rising prevalence of respiratory and airway obstruction diseases is the key growth driver.

3) Which is the largest region during the forecast period in the Global Lung Laryngeal Stents Market?

North America is currently the largest region, while Asia-Pacific is projected to grow fastest.

4) Which segment accounted for the largest market share in the Global Lung Laryngeal Stents Market?

The Silicone Stents segment